Gary John Graham serves as Executive at TransBiotec, Inc., where they oversee executive responsibilities. Since joining the company, Gary John Graham has executed 11 insider transactions totaling $75.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 28, 2024 involved purchasing 98,744 shares valued at $68.1K.
Gary John Graham currently holds 98,744 shares of TransBiotec, Inc. (IMLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary John Graham has been a net buyer of IMLE stock. They have purchased $75.6K and sold $0 worth of shares.
Gary John Graham's most recent insider trade was on May 28, 2024, when they purchased 98,744 shares at $0.69 per share.
Get notified when new Form 4 filings are submitted
| $0.61 |
| Discretionary |
| Feb 29, 2024 | SOBR | $5.3K | Purchase | 8,582 | $0.62 | Discretionary |
| Feb 26, 2024 | SOBR | $732 | Purchase | 1,016 | $0.72 | Discretionary |
| Dec 15, 2020 | SOBR | $0 | Purchase | 2,743,169 | $N/A | Discretionary |
| Dec 7, 2020 | SOBR | $0 | Purchase | 3,103,028 | $N/A | Discretionary |
| Jun 5, 2020 | IMLED | $0 | Purchase | 0 | $N/A | Discretionary |
| Jun 5, 2020 | IMLED | $0 | Purchase | 0 | $N/A | Discretionary |
| Jun 5, 2020 | IMLED | $0 | Award | 12,000,000 | $N/A | Discretionary |
| Feb 15, 2020 | IMLE | $0 | Purchase | 0 | $N/A | Discretionary |
| Dec 12, 2019 | IMLE | $0 | Purchase | 0 | $N/A | Discretionary |